| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |